Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-04-28
1996-04-23
Warden, Jill
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 14, 514 16, 514 17, 530326, A61K 3816, C07K 708
Patent
active
055103286
ABSTRACT:
The present invention provides methods for reducing or inhibiting wound contraction in a subject having a wound comprising administering to the subject a pharmaceutical composition comprising a peptide or a polypeptide. The invention provides, for example, a method of reducing or inhibiting wound contraction comprising the administration of a pharmaceutical composition comprising a peptide having more than three consecutive basic amino acids. The invention also provides a method of reducing or inhibiting wound contraction comprising the administration of a pharmaceutical composition comprising decorin.
REFERENCES:
patent: 4517686 (1985-05-01), Ruoslahti et al.
patent: 4578079 (1986-03-01), Ruoslahti et al.
patent: 4589881 (1986-05-01), Pierschbacher et al.
patent: 4614517 (1986-09-01), Ruoslahti et al.
patent: 4661111 (1987-04-01), Ruoslahti et al.
patent: 4792525 (1988-12-01), Ruoslahti et al.
patent: 5041380 (1991-08-01), Rouslahti et al.
Schreiber, Ronda E. "Reversal of RGD Peptide-Mediated Wound Contraction Enhancement by Incorporation of a Poly-Cationic Sequence." Wounds 6:72 (1994).
Harper, John "The Role of TGF-.beta. and Decorin in Controlling Fibrosis." Wounds 6:70 (1994).
Kresse, H. et al., "Biosynthesis and Interactions of Small Chondrotin/Dermatan Sulphate Proteoglycans." Eur. J. Clin. Chem. Clin. Biochem. 32:259-264 (1994).
Brown, David C. and Vogel, Kathryn G. "Characteristics of the In Vitro Interaction of a Small Proteoglycan (PG11) of Bovine Tendon with Type 1 Collagen." Matrix 9:468-478 (1989).
Vogel, Kathryn G. et al., "Specific Inhibition of Type I and Type II Collagen Fibrillogenesis by the Small Proteoglycan of Tendon." Biochem. J. 223:587-597 (1984).
Greve, Herman et al., "Influence of Collagen Lattice on the Metabolism of Small Proteoglycan II by Cultured Fibroblasts." Biochem. J. 269:149-155 (1990).
Ruoslahti, Erkki, "Structure and Biology of Proteoglycans." Ann. Rev. Cell. Biol. 4:229-255 (1988).
Vogel, Kathryn G. and Trotter, John A. "The Effect of Proteoglycans on the Morphology of Collagen Fibrils Formed in Vitro." Collagen Rel. Res. 7:105-114 (1987).
Polarek, James W. et al., "Development of a Provisional Extracellular Matrix to Promote Wound Healing." Wounds 6:46-53 (1994).
Guidry, Clyde and Grinnell, Frederick "Heparin Modulates the organization of Hydrated Collagen Gels and Inhibits Gel Contraction by Fibroblasts." J. Cell Biol. 104:1097-1103 (1987).
Agrez, M. V. and Chua, F. K. "The Role of Colon Fibroblasts in Malignant Large Bowel Obstruction-an Experimental in Vitro Model." Br. J. Cancer. 62:567-572 (1990).
Gullberg, Donald, et al., ".beta..sub.1 Integrin-Mediated Collagen Gel Contraction is Stimulated by PDGF." Experimental Cell Res. 186:264-272 (1990).
Guidry, Clyde and Grinnell, Frederick "Studies on the Mechanism of Hydrated Collagen Gel Reorganization by Human Skin Fibroblasts." J. Cell Sci. 79:67-81 (1985).
Staatz, William D. et al., "The .alpha..sub.2 .beta..sub.1 Integrin Cell Surface Collagen Receptor Binds to the .alpha.1(I)-CB3 Peptide of Collagen." J. Biol. Chem. 265:4778-4781 (1990).
Donaldson, Donald J. and Mahan, James T. "Newt Epidermal Cell Migration In Vitro and In Vivo Appears to Involve Arg-Gly-Asp-Ser Receptors." J. Cell Science. 87:525-534 (1987).
Smith, Daniel J. et al., "Video Image Analysis of Wound Repair." Wounds 4:6-15 (1992).
Burgess, Maria Lonnett et al., "Integrin-Mediated Collagen Gel Contraction by Cardiac Fibroblasts." Circulation Res. 74:291-298 (1994).
Debhar, Shoukat et al., "A Cell Surface Receptor Complex for Collagen Type Recognizes the Arg-Gly-Asp Sequence." J. Cell Biol. 104: 585-593 (1987).
Agrez, Michael V. et al., "Arg-Gly-Asp-Containing Peptides Expose Novel Collagen Receptors on the Fibroblasts: Implications for Wound Healing." Cell Regulation 2:1035-1044 (1991).
Tomasek, James J. and Akiyama, Steven K. "Fibroblast-Mediated Collagen Gel Contraction Does Not Require Fibronectin-.alpha..sub.5 .beta..sub.1 Integrin Interaction." Anatomical Record 234:153-160 (1992).
Cardarelli, Pina M. et al., "The Collagen Receptor .alpha.2.beta.1, from MG-63 and HT1080 Cells, Interacts with a Cyclic RGD Peptide" J. Biol. Chem. 267:23159-23164 (1992).
Albina, Jorge E. et al., "Regulation of Macrophage Functions by 1-Arginine." J. Exp. Med. 169:1021-1029 (1989).
Albina, Jorge E. et al., "Arginine Metabolism in Wounds." Am. J. Physiol. 254:E459-E467 (1988).
Albina, Jorge E. et al., "Temporal Expression of Different Pathways of 1-Agrinine Metabolism in Healing Wounds." J. Immun. 144:3877-3880 (1990).
Barbul, Adrian et. al., "Intravenous Hyperalimentation with High Arginine Levels Improves Wound Healing and Immune Function." J. Surgical Res. 38:328-334 (1985).
Mills, Charles D. et al., "Concomitant Macrophage Activation and Fibroblast/Lymphocyte Inhibition by Wound Fluid: The Arginine-Deficiency of Inflammation is" a Partial Explanation. Clinical and Experimental Approaches to Dermal and Epiderman Repair: Normal and Chronic Wounds, p:193-203 Wiley-Liss, Inc. (1991).
Grinnell, Frederick et al., "The Collagen Recognition Sequence for Fibroblasts Depends on Collagen Topography." Experimental Cell Res. 182:668-672 (1989).
Grinnell, Frederick "Mini-Review on the Cellular Mechanisms of Disease: Fibroblasts, Myofibroblasts and Wound Contraction." J. Cell Biol. 124:401-404 (1994).
Harper John
Polarek James
Tamura Richard
La Jolla Cancer Research Foundation
Prickril Benet
Warden Jill
LandOfFree
Compositions that inhibit wound contraction and methods of using does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions that inhibit wound contraction and methods of using, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions that inhibit wound contraction and methods of using will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2308511